Suchergebnisse - "Guo, Qinglong"

PubPharm (293)

1

Correction to : Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells

enthalten in: Journal of hematology & oncology | 2019

von Zhao, K. | Zhou, Y. | Qiao, C. | +6

ErratumFor: J Hematol Oncol. 2015 Apr 23;8:41. - PMID 25902914

2

Correction to: Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells

enthalten in: Journal of hematology & oncology | 2019

von Zhao, K. | Zhou, Y. | Qiao, C. | +6

3

Oroxylin A induces apoptosis of activated hepatic stellate cells through endoplasmic reticulum stress

enthalten in: Apoptosis : an international journal on programmed cell death | 2019

von Bian, M. | He, J. | Jin, H. | +6

4

Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors

enthalten in: Bioorganic chemistry | 2019

von Mo, J. | Yang, H. | Chen, T. | +9

5

GL-V9 exerts anti-T cell malignancies effects via promoting lysosome-dependent AKT1 degradation and activating AKT1/FOXO3A/BIM axis

enthalten in: Free radical biology & medicine | 2019

von Hu, P. | Li, H. | Yu, X. | +10

6

Corrigendum to "Selective anti-tumor activity of wogonin targeting the Warburg effect through stablizing p53" [Pharmacol. Res. 135 (2018) 49-59

enthalten in: Pharmacological research | 2019

von Zhao, Y. | Zhang, L. | Wu, Y. | +6

ErratumFor: Pharmacol Res. 2018 Sep;135:49-59. - PMID 30031170

7

Corrigendum to "Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein" [Toxicology and Applied Pharmacology 271 (2013) 144-145

enthalten in: Toxicology and applied pharmacology | 2019

von Song, X. | Yao, J. | Wang, F. | +8

ErratumFor: Toxicol Appl Pharmacol. 2013 Sep 1;271(2):144-55. - PMID 23707765

8

Corrigendum to "HQS-3, a newly synthesized flavonoid, possesses potent anti-tumor effect in vivo and in vitro" [European Journal of Pharmaceutical Science (2013) 649-658

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2019

von Zhou, Y. | Lu, N. | Zhang, H. | +7

ErratumFor: Eur J Pharm Sci. 2013 Jul 16;49(4):649-58. - PMID 23619285

9

Mitotic catastrophe and p53-dependent senescence induction in T-cell malignancies exposed to nonlethal dosage of GL-V9

enthalten in: Archives of toxicology | 2019

von Li, H. | Hu, P. | Wang, Z. | +9

10

Mitotic catastrophe and p53-dependent senescence induction in T-cell malignancies exposed to nonlethal dosage of GL-V9

enthalten in: Archives of toxicology | 2019

von Li, H. | Hu, P. | Wang, Z. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[30]